GRI Bio, Inc. (GRI)
NASDAQ·Healthcare·Biotechnology
$2.36
-1.05%
Mkt Cap $224.58K
No analyst coverage available
We don't have analyst ratings or price target data for GRI Bio, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.